13.09.2022 Views

Molecular Biology of the Cell by Bruce Alberts, Alexander Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter by by Bruce Alberts, Alexander Johnson, Julian Lewis, David Morg

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CANCER AS A MICROEVOLUTIONARY PROCESS

1099

differentiated tissue

oxidative

phosphorylation

NET PRODUCTS:

glucose

ENERGY, CO 2 , H 2 O

(A)

GLYCOLYSIS

pyruvate

lactate

proliferative

tissue

oxidative

phosphorylation

NET PRODUCTS:

glucose

tumor

10%

GLYCOLYSIS

pyruvate

5% 85%

lactate

ENERGY, BUILDING BLOCKS,

NADPH

(B)

building

blocks

effect—so named because Otto Warburg first noticed the phenomenon in the early

twentieth century. It is this abnormally high glucose uptake that allows tumors to

MBoC6 n20.201/20.12

be selectively imaged in whole-body scans (see Figure 20–1), thereby providing a

way to monitor cancer progression and responses to treatment.

Figure 20–12 The Warburg effect in

tumor cells reflects a dramatic change in

glucose uptake and sugar metabolism.

(A) Cells that are not proliferating will

normally oxidize nearly all of the glucose

that they import from the blood to produce

ATP through the oxidative phosphorylation

that takes place in their mitochondria. Only

when deprived of oxygen will these cells

generate most of their ATP from glycolysis,

converting the pyruvate produced to lactate

in order to regenerate the NAD + that they

need to keep glycolysis going (see Figure

2–47). (B) Tumor cells, by contrast, will

generally produce abundant lactate even

in the presence of oxygen. This results

from a greatly increased rate of glycolysis

that is fed by a very large increase in the

rate of glucose import. In this way, tumor

cells resemble the rapidly proliferating

cells in embryos (and during tissue repair),

which likewise require for biosynthesis a

large supply of the small-molecule building

blocks that can be produced from imported

glucose (see also Figure 20–26).

Cancer Cells Have an Abnormal Ability to Survive Stress and DNA

Damage

In a large multicellular organism, there are powerful safety mechanisms that

guard against the trouble that can be caused by damaged and deranged cells. For

example, internal disorder gives rise to danger signals in the faulty cell, activating

protective devices that can eventually lead to apoptosis (see Chapter 18). To

survive, cancer cells require additional mutations to elude or break through these

defenses against cellular misbehavior.

Cancer cells are found to contain mutations that drive the cell into an abnormal

state, where metabolic processes may be unbalanced and essential cell components

may be produced in ill-matched proportions. States of this type, where the

cell’s homeostatic mechanisms are inadequate to cope with an imposed disturbance,

are loosely referred to as states of cell stress. As one example, chromosome

breakage and other forms of DNA damage are commonly observed during the

development of cancer, reflecting the genetic instability that cancer cells display.

Thus, to survive and divide without limit, a prospective cancer cell must accumulate

mutations that disable the normal safety mechanisms that would otherwise

induce a cell that is stressed, in this or in other ways, to commit suicide. In fact,

one of the most important properties of many types of cancer cells is that they fail

to undergo apoptosis when a normal cell would do so (Figure 20–13).

While cancer cells tend to avoid apoptosis, this does not mean that they rarely

die. On the contrary, in the interior of a large solid tumor, cell death often occurs

on a massive scale: living conditions are difficult, with severe competition among

the cancer cells for oxygen and nutrients. Many die, but typically much more by

necrosis than by apoptosis (Figure 20–14). The tumor grows because the cell birth

rate outpaces the cell death rate, but often by only a small margin. For this reason,

the time that a tumor takes to double in size can be far longer than the cell-cycle

time of the tumor cells.

Human Cancer Cells Escape a Built-in Limit to Cell Proliferation

Many normal human cells have a built-in limit to the number of times they can

divide when stimulated to proliferate in culture: they permanently stop dividing

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!